| 000 | 05819nam a22003975i 4500 | ||
|---|---|---|---|
| 999 |
_c392989 _d392989 |
||
| 001 | 392989 | ||
| 003 | ES-MaUEC | ||
| 005 | 20231209133343.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 110806s2011 xxu| fo |||| 0|eng d | ||
| 020 | _a9781617792014 | ||
| 024 | 7 |
_a10.1007/978-1-61779-201-4 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQH588 .S83 _b2011 EB |
|
| 245 | 0 | 0 |
_aHuman Pluripotent Stem Cells _bMethods and Protocols _cedited by Philip H. Schwartz, Robin L. Wesselschmidt |
| 250 | _a1st edition 2011 | ||
| 264 | 1 |
_aTotowa, NJ _bHumana Press _c2011 |
|
| 300 |
_a1 recurso en línea (XIX, 468 páginas) _b89 ilustraciones, 43 ilustraciones a color |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aMethods in Molecular Biology _x1940-6029 _v767 |
|
| 505 | 0 | _aThe Stem Cell Laboratory: Design, Equipment, and Oversight -- Stem Cell Banks: Preserving Cell Lines, Maintaining Genetic Integrity, and Advancing Research -- Embryonic Stem Cell Derivation from Human Embryos -- Derivation of Human Parthenogenetic Stem Cell Lines -- Generation of Induced Pluripotent Stem Cell Lines from Human Fibroblasts via Retroviral Gene Transfer -- Derivation of Induced Pluripotent Stem Cells by Lentiviral Transduction -- Transgene-free Production of Pluripotent Stem Cells using PiggyBac Transposons -- Traditional Human Embryonic Stem Cell Culture -- Xeno-Free Culture of Human Pluripotent Stem Cells -- Adaptation of Human Pluripotent Stem Cells to Feeder-Free Conditions in Chemically-Defined Medium with Enzymatic Single-Cell Passaging -- GMP Scale-Up and Banking of Pluripotent Stem Cells for Cellular Therapy Applications -- Culture of Human Pluripotent Stem Cells on Glass Slides for High-Resolution Imaging -- Classical Cytogenetics: Karyotyping Techniques -- FISH Analysis of Human Pluripotent Stem Cells -- Immunocytochemical Analysis of Human Pluripotent Stem Cells -- Flow Cytometric Analysis of Human Pluripotent Stem Cells -- The Teratoma Assay: An In vivo Assessment of Pluripotency -- Detection of Copy Number Variation using SNP Genotyping -- Genome-wide Epigenetic Analysis of Human Pluripotent Stem Cells by ChIP and ChIP-Seq -- Basic Approaches to Gene Expression Analysis of Stem Cells by Microarrays -- Development of High Content Screening Approaches and Analysis for Human Pluripotent Stem Cells -- Quantitative Proteome and Phosphoproteome Analysis of Human Pluripotent Stem Cells -- Lentivirus-mediated Modification of Pluripotent Stem Cells -- Nucleofection of Human Embryonic Stem Cells -- Non-viral Gene Delivery in Neural Progenitors Derived from Human Pluripotent Stem Cells -- Gene Targeting in Human Pluripotent Stem Cells -- Episomal Transgene Expression in Pluripotent Stem Cells -- The Generation of Embryoid Bodies from Feeder-based or Feeder-free Human Pluripotent Stem Cell Cultures -- Derivation of Oligodendrocyte Progenitor Cells from Human Embryonic Stem Cells -- Directed Differentiation of Dopamine Neurons From Human Pluripotent Stem Cells -- Methods for the Derivation and Use of Cardiomyocytes from Human Pluripotent Stem Cells -- In Vivo Evaluation of Putative Hematopoietic Stem Cells Derived from Human Pluripotent Stem Cells -- Differentiation of Dendritic Cells from Human Embryonic Stem Cells. | |
| 520 | _aAlmost daily, new technologies are being presented that move the field of human pluripotent stem cell research towards a future that may yield highly-effective, personalized medical treatments. Three enabling technologies at hand for human PSCs are 1) directed reprogramming of somatic cells, which eliminate many of the ethical issues associated with the derivation and use of human PSCs, increase genetic diversity of the available human PSC lines, and give rise to better in vitro human disease models; 2) the discovery that a Rho-associated protein Kinase (ROCK) inhibitor allows for efficient single cell passaging and cryopreservation, increasing the efficiency and reliability of hPSC culture; and 3) defined, animal-component-free media, which lay the groundwork for simplified scale-up for therapeutic applications, differentiation protocols, and toxicology screens. The aforementioned technologies can be found in Human Pluripotent Stem Cells: Methods and Protocols, a compilation of 33 detailed protocols in six categories of PSC research that cover laboratory essentials and the derivation of new PSC lines, including induced PSC lines, as well as their growth, maintenance, characterization, genetic manipulation, and differentiation. Written in the successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and accessible, Human Pluripotent Stem Cells: Methods and Protocols serves as an ideal guide to scientists conducting their own pluripotent cell research programs and makes great strides towards furthering human knowledge and, ultimately, improving the human condition. | ||
| 988 | _aSpringer_Protocols_2011 | ||
| 650 | 7 |
_2embne _9160528 _aCélulas madre |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9781617792007 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781617792021 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781493958023 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-61779-201-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b12/2023 _dz _ean _zSI |
||